GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neuroscientific Biopharmaceuticals Ltd (ASX:NSB) » Definitions » Other Gross PPE

Neuroscientific Biopharmaceuticals (ASX:NSB) Other Gross PPE : A$0.00 Mil (As of Dec. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Neuroscientific Biopharmaceuticals Other Gross PPE?

Neuroscientific Biopharmaceuticals's Other Gross PPE for the quarter that ended in Dec. 2024 was A$0.00 Mil.


Neuroscientific Biopharmaceuticals Other Gross PPE Historical Data

The historical data trend for Neuroscientific Biopharmaceuticals's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neuroscientific Biopharmaceuticals Other Gross PPE Chart

Neuroscientific Biopharmaceuticals Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Other Gross PPE
Get a 7-Day Free Trial - - - - -

Neuroscientific Biopharmaceuticals Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Neuroscientific Biopharmaceuticals Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Neuroscientific Biopharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
a Street, Suite 5, Cottesloe, Perth, WA, AUS, 6011
Neuroscientific Biopharmaceuticals Ltd is an Australian-based biotechnology company. The company is engaged in the development of diagnostic and therapeutic treatments for neurodegenerative diseases through preclinical studies of patented technologies.

Neuroscientific Biopharmaceuticals Headlines

No Headlines